Mirikizumab: A New Therapeutic Option for the Treatment of Ulcerative Colitis.

Published in: The Annals of pharmacotherapy (2024)

Mirikizumab provides a novel mechanism of action for the treatment of moderate to severe UC and is another welcomed treatment advance in the treatment arsenal, providing a more selective mechanism of action while maintaining a comparable safety profile.

Keyphrases

replacement therapy
smoking cessation